Genetic studies point to a major role of de novo mutations in neurodevelopmental disorders of intellectual disability, autism spectrum disorders, and epileptic encephalopathy. The STXBP1 gene encodes the syntaxin-binding protein 1 (Munc18-1) that critically controls synaptic vesicle exocytosis and synaptic transmission. This gene harbors a high frequency of de novo mutations, which may play roles in these neurodevelopmental disorders. However, the system and behavioral-level pathophysiological changes caused by these genetic defects remain poorly understood. Constitutional (Stxbp1 /Vgat mice showed increased aggressiveness. Pharmacological potentiation of the excitatory transmission at active synapses via the systemic administration of ampakine CX516, which enhances the excitatory postsynaptic function, ameliorated the aggressive phenotype of Stxbp1 þ/À mice. These findings suggest that synaptic impairments of the dorsal telencephalic and subcortical excitatory neurons cause learning deficits and enhanced aggression in Stxbp1 þ/À mice, respectively. Additionally, normalizing the excitatory synaptic transmission is a potential therapeutic option for managing aggressiveness in patients with STXBP1 mutations.
Introduction
Regulated synaptic transmission underlies normal brain functioning, while its dysregulation causes various pathological states (1, 2) . The Stxbp1 gene encodes syntaxin-binding protein 1 (Munc18-1), which is a synaptic protein indispensable for neurotransmitter release (3, 4) . Munc18-1 binds to syntaxin and interacts with the soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNARE) complex, regulating docking and fusion of synaptic vesicles to presynaptic membranes (5) . Homozygous deletions of Stxbp1 resulted in complete loss of glutamatergic and gamma-aminobutyric acid (GABA)ergic neurotransmitter release (3) . In heterozygous Stxbp1 knockout mice, the synaptic transmission rapidly drops during repetitive stimulations due to the limited size of readily releasable pools (4) .
Human genetic studies have linked STXBP1 mutations with a broad spectrum of neurodevelopmental diseases. STXBP1 mutations have been described in patients with epileptic encephalopathies including Ohtahara syndrome that is associated with severe intellectual disabilities (6) (7) (8) (9) . These mutations have also been reported in cases with intellectual disabilities (10, 11) and autism spectrum disorders (ASD) (10, (12) (13) (14) . According to a comprehensive review of patients with STXBP1 mutations, almost all patients exhibited epilepsy and intellectual disability, 20% were autistic, and some exhibited increased aggressive behaviors (13) . Consistently, neurodevelopmental, psychiatric, and neurological disorders have been occasionally associated with aggressiveness (15) (16) (17) . Animal models with Stxbp1 mutation may therefore provide mechanistic insights into the neurodevelopmental disorders associated with intellectual disabilities and aggression. Heterozygous Stxbp1 knockout (Stxbp1 þ/À ) mice are outwardly healthy and fertile, though homozygous Stxbp1 knockout mice are lethal (3) . Enhanced anxiety-like emotional response assessed based on heart rate was reported in Stxbp1 þ/À mice in novel open field and fear-conditioning tests (18) . Transgenic mice with Stxbp1 overexpression displayed schizophrenic behavior (19) . Thus, deviations from the normal level of Munc18-1 protein and the resultant synaptic deficits may trigger neurodevelopmental disorders such as autism and neuropsychiatric symptoms; however, it remains undescribed how dysfunction of synaptic transmission causes behavioral abnormalities from cognition to social interaction related to neurodevelopmental disorders. Here, we directly addressed this question by characterizing behavioral phenotype of constitutive or conditional Stxbp1 knockout mice, and found impaired excitatory neurotransmission-dependent cognitive deficits and increased aggressiveness in Stxbp1 þ/À mice and amelioration of the aggressive phenotype by potentiating excitatory transmission.
Results

Generation of floxed Stxbp1 and knockout mice
We generated mice with a floxed exon 3 of Stxbp1 gene and subsequently knockout mice by mating with EIIA-Cre driver mice ( Fig. 1A and B). weeks after birth). The Stxbp1 þ/À mice had a normal appearance indistinguishable from WT mice except for a lower body weight (Fig. 1C) , which is in line with previous findings (18) . Our results confirmed the reduced expression of Munc18-1 protein in Stxbp1 þ/À mice and its absence in embryonic Stxbp1 À/À mice ( Fig. 1D and E).
Environmental stimuli-dependent increase of anxiety in Stxbp1 þ/À mice
In the novel open field activity test, the total distance moved and movement speed of Stxbp1 þ/À mice were equivalent to those of WT mice ( Fig. 2A and B) . Time spent in the center of the arena, reflecting the anxiety level, was also similar to WT mice (Fig. 2C ), but the rearing number, an index of repetitive behavior, was significantly lower in Stxbp1 þ/À mice than in WT mice (Fig. 2D ).
We noticed that Stxbp1 þ/À mice often displayed hyperactive responses to the experimenter during handling. To examine further the emotional response, we investigated the anxietyrelated behavior in Stxbp1 þ/À mice using the elevated plus maze and the light-dark transition test. The total distance traveled, time spent in the open or closed arms, and the numbers of entry to the open or closed arms did not differ significantly between WT and Stxbp1 þ/À mice on the elevated plus maze (Fig. 2E-G) . In contrast, the time spent in the dark box in the light-dark transition test was significantly longer in the Stxbp1 þ/À mice than the WT mice ( Fig. 2H-J Fig. S1A and B). The reduced freezing in Stxbp1 þ/À mice is unlikely to be caused by a low sensitivity to the fear stimulus, because the estimated anxiety levels of Stxbp1 þ/À mice were comparable or even slightly increased compared with WT mice in the elevated plus maze, light-dark box test, and novel open field activity test (Fig. 2) . These results are consistent with a recent report that demonstrated increased fear and anxiety in Stxbp1 þ/À mice using heart rate measurements (18) . In the same report, however, auditory delay and trace fear conditioning were significantly enhanced in Stxbp1 þ/À mice. This discrepancy with our observations can be attributed to the methods used for quantifying the fear responses; freezing response was used in our study, while heart rate was used in the previous study (18) . Gamma activity has been assumed to underlie cognitive processing (21, 22) , and its abnormalities were reported in models of psychiatric disorders including schizophrenia and autism (23, 24) . Therefore, we measured electrocorticogram (ECoG) and local field potentials (LFPs) in WT and Stxbp1 þ/À mice before and after fear conditioning (Fig. 3E -J and Supplementary Material, Fig. S2 ). In this experiment, we used naive mice for the fear-conditioning test, which again failed to form fear memory (Supplementary Material, Fig. S2A ). Prior to the fear conditioning, the gamma (50-70 Hz) activity of awake mice during baseline recordings was significantly decreased in the hippocampal CA1 region of Stxbp1 þ/À mice ( Fig. 3E and I, Supplementary Material, Fig. S2B ). Twenty-four hours after fear conditioning, we observed a significantly higher gamma activity in the medial prefrontal cortex (mPFC), basolateral amygdala (BLA), and ventroposterior thalamus (VP) of Stxbp1 þ/À mice compared with WT mice ( Fig. 3H and J, Supplementary Material, Fig. S2C ) during the tone presentation. However, there was no statistical difference in the time freezing in the neutral chamber before the tone presentation (Supplementary Material, Fig. S2D Fig. 4A and B ).
Subsequently, we tested social interaction between freely moving male mice in the open field ( Fig. 4C and D) . We quantified active contacts by WT or Stxbp1 þ/À mice to unfamiliar mice (C57B6), including sniffing, touching, and following. The Stxbp1 þ/À mice exhibited a significantly larger number and longer duration of active contacts than the WT mice. Because attacking behaviors were occasionally observed in Stxbp1
mice in the open field interaction test, we further quantified the aggressiveness of Stxbp1 þ/À mice using the resident-intruder test ( Fig. 4E-H) . The latency to the first aggressive behavior (attacking, biting) against the intruder (C57B6 young male mouse) was significantly shorter (Fig. 4E) , and the duration and number of aggressive responses against the intruder were also significantly higher in resident Stxbp1 þ/À mice ( Fig. 4F /Vgat mice, however, did not exhibit enhanced aggressiveness, but rather displayed a lower tendency ( Fig. 5O-R) . Consistently, we did not observe inter-male aggression in their home cages. These results suggest that non-dorsal telencephalic subcortical brain structures are responsible for the enhanced aggressiveness in Stxbp1 þ/À mice, while reduced excitatory synaptic transmission in the dorsal telencephalon primarily contributes to the impaired fear-learning.
Mitigation of aggressiveness in Stxbp1 þ/À mice by potentiating excitatory transmission
Haploinsufficiency of Stxbp1 results in faster rundown of excitatory synaptic transmission (4) . Therefore, we hypothesized that recovering the excitatory synaptic transmission may mitigate aggressiveness in Stxbp1 þ/À mice. Ampakines potentiate the function glutamatergic alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor by slowing the deactivation and desensitization of ion channels; they are only effective in the presence of glutamate at synapses (27) . Ampakines have been widely used as cognitive enhancers in normal animals or animal models with cognitive impairments (27) . At comparable doses, which are reported to improve various types of memory performance, CX516, a first-generation ampakine with a short half-life (28), or vehicle was intraperitoneally administered to Stxbp1 þ/À mice 10 min prior to the resident-intruder test. While vehicletreated Stxbp1 þ/À mice still showed robust aggressiveness against the intruders, CX516-treated mice significantly decreased (40 mg/ kg) and totally suppressed (100 mg/kg) their aggressive responses (Fig. 6A ). Sniffing was unchanged at 40 mg/kg, but significantly decreased at 100 mg/kg compared with vehicle-treated mice (Fig.  6B ). CX516-treated Stxbp1 þ/À mice remained occasionally at a distance from the intruder mouse, a behavior that was also observed in CX516-treated WT mice (n ¼ 6). No sluggish or dyskinetic movements were observed (Supplementary Material, Movie S2). Furthermore, no significant impairments in motor coordination in the CX516-treated Stxbp1 þ/À mice were observed on the rotarod test (Fig. 6C) . We additionally performed the light-dark transition 
Discussion
In this study, we demonstrated that impaired synaptic transmission in Stxbp1 þ/À mice results in cognitive deficits and enhanced aggressiveness, which was pharmacologically ameliorated by potentiating excitatory postsynaptic function. We also observed mild epileptic phenotypes in the mice (Miyamoto et al., in preparation). Despite the high homology of Munc18-1 between human and mouse, the phenotypic severity in mice with Munc18-1 haploinsufficiency is moderate compared with that in humans, and the reasons for these differences are currently unknown. Indeed, the mouse models carrying human disease mutations do not always fully recapitulate the disease phenotype of the patients. For instance, we have previously shown that Scn1a knockout mice well reproduced the severe phenotype of Dravet syndrome (26, 29) , while the phenotype of laforin knockout mouse phenotype was considerably milder than that reported in patients with Lafora disease (30) . Impulsive aggression is often associated with various types of psychiatric and neurodevelopmental disorders, including schizophrenia, clinical depression, epilepsy, ASD, and attention-deficit/hyperactivity disorder (15, 17, (31) (32) (33) . Patients with intellectual disabilities or neurodegenerative diseases such as Alzheimer's disease are also at a high-risk of aggressive behaviors (34, 35) . Stxbp1 þ/À mice recapitulate clinical features of these disorders. Although Ohtahara syndrome in many newborn patients (typically within 3 months) is caused by de novo STXBP1 mutations (6), enhanced aggressiveness has not been described so far, likely due to the severe mental retardation and motor deficits. However, seventy-five percent of patients with Ohtahara syndrome (within 3 months of age) transit to West syndrome (mostly within 1 year), and 59% of those with West Resident-intruder test in Stxbp1 þ/À (n ¼ 10) and WT (n ¼ 10) male mice (7 months of age). Stxbp1 þ/-mice showed enhanced aggressiveness (10-min test period) against an intruder mouse (C57BL/6N, male, 6 weeks) with a significantly shorter latency to attack (E) (t-test, t ¼ 5.396, ***P < 0.0001; 600 s were assigned to mice that did not attack), longer aggression duration (F) (t18 ¼ 6.574, **P < 0.0001), and higher aggression number (G) (t18 ¼ 6.313, ***P < 0.0001). Sniffing duration (H) was shorter in Stxbp1 þ/À mice (t 18 ¼ 4.665, ***P ¼ 0.0002). syndrome further evolve to Lennox-Gastaut syndrome (1 year or later) (9), which display aggressive behaviors at high rates (36, 37) . Therefore, Stxbp1 þ/À mice should serve as a model for aggression in neurodevelopmental disorders. To our knowledge, the present study is the first to report on the mitigation of aggression through the activation of glutamatergic AMPA receptors. Memory improvements by ampakines such as CX516 have been repeatedly documented in the literature (27, 28, 38, 39) . The administration of CX516 has been previously reported to reduce the spontaneous locomotor activity in a dose dependent manner (40, 41) . Therefore, CX516 might reduce aggressive behaviors due to possible adverse effects on brain and behavior. However, our results indicated that the aggressive behavior was significantly (40 m/kg) and drastically (100 mg/kg) suppressed, while putative non-aggressive behaviors such as sniffing was either not affected (40 m/kg) or reduced by 50% following the 100 mg/kg dosage. Even at a higher CX516 dose (100 mg/kg), the motor performance on the rotarod test was only modestly affected. Previous studies have reported significant improvements in learning and memory after the administration of CX516 at 35 mg/kg in fear conditioning (38) , spatial delayed non-match-to-sample task (28) , and olfactory learning (40) , and at 80 mg/kg in the novel object recognition task (42) . It is worth noting that these tasks require high cognitive abilities and motivation, thus indicating minimal to absent adverse effects of CX516. Moreover, CX516 at 40 mg/kg relieved depressive symptoms of pain (43) . Thus, the effect of CX516 on aggressiveness in our model is unlikely due to non-specific sedative or adverse effects.
Several studies reported that glutamate stimulation facilitates aggressiveness, suggesting that glutamatergic inputs to the hypothalamic attack area or the raphe nucleus promote aggression, while blockade of glutamate receptors reduces aggression [reviewed in (44) ]. The basis of the contradictory glutamatergic actions on aggression in the current and previous studies is so far unknown. However, it could stem from different contributions of glutamate receptor subtypes (e.g. AMPA, NMDA, kainite, and metabotropic glutamate receptors) (44), brain regions (e.g. prefrontal cortex, amygdala, hypothalamus, nucleus accumbens, habenula, and raphe nucleus) (44, 45) , or use-dependent actions of the ampakine (27) . A recently introduced anti-epileptic drug 'perampanel,' which is a non-competitive antagonist of AMPA receptors, was reported to induce aggressive behaviors frequently in patients with epilepsy (46) . Thus, it may be of interest to explore whether STXBP1 mutations are also a marker for patients with epilepsy who are at risk of developing aggression in response to perampanel treatment.
Our present results showed that, unlike Stxbp1 þ/À mice,
Stxbp1
fl/þ /Emx mice and Stxbp1 fl/þ /Vgat mice did not exhibit increased aggressiveness. These findings suggest that impaired excitatory neurotransmission in non-dorsal telencephalic subcortical brain structures are responsible for inducing increased aggressiveness in Stxbp1 þ/À mice. There are several mouse models with enhanced aggression (47) . Particularly, hypofunction of the brain serotonergic system has been suggested to accelerate aggressiveness (48, 49) . Therefore, we propose that reduced glutamatergic inputs to the raphe nucleus (50) or reduced serotonergic transmission caused by Stxbp1 haploinsufficiency may contribute to the enhanced aggressiveness in both mice and patients. Urigü en and colleagues (19) reported an elevated level of anxiety in mice overexpressing Munc18-1, while in the present study Stxbp1 þ/À mice also showed elevated anxiety. This may derive from the varying behavioral paradigms used. Their study performed the open field and elevated plus maze tests, while our present study used the light-dark transition test. Alternatively, deviations from the optimal level of neurotransmission may similarly affect the level of anxiety. Contextual and cue-evoked fear conditioning require proper functioning of the amygdala, while contextual fear conditioning is hippocampus dependent (51) . Since Stxbp1 þ/À mice displayed deficits in cue-evoked fear conditioning, impaired functions of /Vgat mice. However, these mice have similar memory deficits. Since the brain glutamatergic and GABAergic neurons are both involved in fear learning (52) in ways of excitatory, inhibitory, or disinhibitory manners, it is possible that the dysfunction of either neurotransmitter system may consequently hamper fear learning. Alternatively, fear-learning paradigm which focuses on freezing response might not be sufficient to distinguish differences between them in fear-memory processing. In addition, dissociations of fear-learning and cognitive abilities have been reported (53, 54) .
Endocannabinoids suppress the synaptic transmission through the phosphorylation of Munc18-1 (55, 56) , thus serving the homeostatic control of synaptic strength through negative feedback. In particular, endocannabinoids are implicated in fear, anxiety, synaptic plasticity, and learning (57) . These findings are indeed consistent with our present results in Stxbp1 þ/ À mice. We also observed differences between WT and Stxbp1 þ/À mice in the gamma activity elicited by fear conditioning in multiple brain regions. Gamma activity is believed to be associated with various cognitive functions such as attention, sensory perception, learning/memory, and social activity (21, 22) , and may also underlie neural computations and inter-regional communications (58) . Therefore, the abnormal gamma activity in Stxbp1 þ/À mice may affect neuronal processing and coordination among brain regions. Significantly higher LFP gamma activities in the mPFC, amygdala, thalamus, and hippocampus of Stxbp1 þ/À mice suggest that these brain regions are responsible for the impaired fear memory formation. Indeed, these brain regions have been previously implicated in fear memory (52, 59) . Aberrant gamma oscillations have also been implicated in neuropsychiatric diseases such as schizophrenia and ASD (24) . Excessive gamma activity was reported in young patients with ASD (23) and in an animal of schizophrenia (60) . Furthermore, impairments of social behavior and conditional learning together with increased gamma power have been associated with the selective activation of PFC pyramidal neurons (61) . Thus, neuronal dysfunction caused by excessive gamma activity could explain the deficits in learning/memory and emotional processing in Stxbp1 þ/À mice. Thus, the aberrant regional gamma activity could be a biomarker of these disorders. Our findings would be applicable to understand a broad spectrum of neurodevelopmental and psychiatric diseases with synaptic deficits, and provide insights into the role of excitatory transmission in aggression. Furthermore, while atypical antipsychotics are often used to treat clinical aggression in schizophrenia, autism, or dementia (33, (62) (63) (64) , our present study offers new possibilities of therapeutic alternatives to manage aggression by normalizing excitatory transmission.
Materials and Methods
All animal experimental protocols were approved by the Animal Experiment Committee of RIKEN Brain Science Institute. Mice were handled in accordance with the guidelines of the Animal Experiment Committee. Food and water were available ad libitum, and cages were kept at 23 C and 55%
humidity on a 12-h light/dark cycle with the lights off at 20: 00. All mice were housed in groups of two to five mice per cage until behavioral tests.
Stxbp1 constitutional and conditional knockout mice
Stxbp1 floxed mice were produced by homologous recombination using the C57BL/6N-derived ES cell line RENKA (65) . A genomic fragment carrying exon 2-6 of the Stxbp1 gene was isolated by PCR from C57BL/6N genome. A DNA fragment carrying the loxP sequence and neomycin-resistance cassette flanked by two frt sites was inserted into the site 162 bp upstream of the exon 3, while the other loxP sequence was inserted into the site 159 bp downstream of the exon 3. The targeting vector contained the floxed exon, 3.5 kb upstream and 6.5 kb downstream genomic sequences, and 4.3 kb pMC1DTpA. Establishment of targeted ES clones and generation of chimeras were performed as described previously (65) . Stxbp1 floxed mice were maintained on a C57BL/6N background. To generate Stxbp1 knockout mice, Stxbp1 fl/þ mice were cross-mated with EIIA-Cre mice (66) .
Heterozygous (Stxbp1 fl/þ /EIIA-Cre) offspring were subsequently backcrossed with C57BL/6N mice to obtain Stxbp1 þ/À mice lacking the EIIA-Cre transgene. Empty spiracles homolog 1 (Emx1)-Cre knock-in line (25, 67) and Vesicular GABA transporter (Vgat)-Cre BAC transgenic line (26) was described previously, and maintained on a C57BL/6J background.
Western blot analysis
Brains were removed from mice and cortex and hippocampus were dissected, frozen in liquid nitrogen, and stored at À80 C until analyzed. 
Elevated-plus maze test
The elevated-plus maze test was performed as previously described (68 
Light-dark transition test
The light-dark transition test was performed as previously described (68) . 
Y-maze test
In Y-maze test (69) , size of each arm is 40 cm long, 12 cm high, 3 cm wide at the bottom and 10 cm wide at the top. After placing a mouse at the end of an arm, the mouse was allowed to move freely through the maze during a 5 min test session. A sequence of arm entries was used for calculation of an alternation which is defined as the number of entries into all three arms sequentially. The percent alternation is calculated as (actual alternations/maximum alternations) Â100.
Three-chambered social interaction test
The apparatus was a rectangular, three chambered box made from non-transparent, gray plates, which was placed in a soundproof outer box (68) (O'Hara & Co.). Two transparent partitions divide the box into three identical 20-cm-long chambers. Square openings in the bottom of the partitions allowed mice to move among the three chambers. A stranger moue (C57BL/6J males, 8 weeks) was placed in a cage with vertical grid, and the stranger mouse was habituated in the cage for 10 min before the test. Initially, a test mouse was placed in the center chamber of the three-chambered box, where empty cages with vertical grid were located on the corner of the both side chambers, and allowed to explore the entire box for 10 min ('emptyempty'). Next, the empty cage was replaced with the wire cage containing the stranger mouse ('stranger-empty'), then the test mouse was allowed to explore the test box for 10 min (test for sociability). Time spent around each cage, time spent in each chamber and total distance traveled were automatically quantified. ), mean duration per contact and total duration of contact were quantified by the investigator blinded to genotypes of the mice. Active contact includes attacking, sniffing, touching, following, and chasing by the test mice.
Open field interaction test
Resident-intruder test
Stxbp1
þ/À or WT resident test mice were housed in home cages individually for over 7 days before the test (70) . After introducing a male intruder mouse (C57BL/6N, 6 weeks) to the home cage (28 Â 17 Â 13 cm, 70 lux) of the resident mouse (WT or Stxbp1 þ/À ), the duration and number of attack, pursuit/chasing and sniffing by the resident mice for 10 min were scored by the investigator blinded to genotypes of the mice.
Contextual fear and cue-evoked fear memory test
Fear conditioning (71) was performed in a translucent plastic chamber with a stainless-steel grid floor (10 Â 10 Â 10 cm, 210 lux) in a soundproof box with white noise (50 dB). Initially, a mouse was allowed to explore the chamber for 3 min, and received three pairs of conditioned stimulus (CS: 60 dB white noise for 30 s) and unconditioned stimulus (US: 0.3 mA electrical foot shock for 2 s) delivered at the last 2 s of the CS period. The interval between the CS-US pairings was set to 1 min. After the end of the CS-US presentation, the mouse remained in the chamber for 1 min and was returned to the home cage. Twentyfour hours after the conditioning, contextual fear memory was tested in the same conditioning chamber for 3 min without the CS and US. Auditory cue-evoked fear memory test was performed in a test chamber distinct from the conditioning chamber in shape (triangular prism), luminance (50 lux), floor (paper chips bedding) and background white noise (60 dB). Twenty-four hours after the conditioning, the mouse was put in the test chamber for 3 min exploration, and then 10 pairs of CS alone were presented (65 dB white noise for 30 s). The interval between the CS was set to 30 s. Following the CS presentation, the mouse remained in the chamber for another 1 min. Freezing response (immobility excluding respiration) of the mice was automatically quantified by ImageJ software (O'Hara). Once mice were used for fear memory test, behavioral experiments of the mice were terminated.
Rotarod test
The tests using an accelerating-rotarod (72) were conducted for consecutive 3 days. On the first day, animals were habituated to the rotarod apparatus (Muromachi Kikai Co., Ltd., Tokyo, Japan) at constant 4 rpm for 30 s. Four trials on the rotarod linearly accelerating from 4 to 40 rpm in 300 s were performed in a day with a 600 s interval. The latency when the mouse fell off was recorded.
Drug administration
In the resident-intruder and rotarod tests, mice were injected vehicle (saline, 5 ml/g of body weight), low CX516 (40 mg/kg, 8 mg/ml in saline) or high CX516 (100 mg/kg, 20 mg/ml in saline) intraperitoneally 10 min before the tests.
Cue-evoked fear conditioning combined with somatosensory electrocorticogram (S1 ECoG) and local field potential (LFP) recordings Stainless steel screws (1.1 mm diameter) served as S1 ECoG electrode was placed over the right somatosensory cortex (1.0 mm posterior to bregma, 1.5 mm to the midline) (73) . A stainless screw as a reference and ground electrode was placed on the cerebellum. Stainless wire monopolar electrode was inserted in the cervical region of the trapezius muscle for electromyogram (EMG). For monopolar local field potential (LFP) recordings of brain regions, stainless wires (200 lm diameter) were stereotaxically implanted contralateral to the ECoG electrode according to the following coordinates (anterior-posterior, mediallateral, depth from the cortical surface, mm): medial prefrontal cortex (1.9, 0.3, 1.4), caudate-putamen (0.0, 2.4, 2.5), basolateral amygdala (À1.4, 2.9, 3.7), ventroposterior thalamus (À1.8, 1.5, 3.2), hippocampus CA1 region (À2.5, 2.2, 1.1), visual cortex binocular zone (À3.4, 3.0, 0.4). Contacts between the electrode and brain surface were covered with a small amount of Vaseline and secured with dental acrylic. An antibiotic (ampicillin) was used in surgery. After at least 1 week recovery from implant surgery, the animals were tethered to a 16-channel commutator (Plexon, Dallas, TX) and allowed to move freely during recording in an electrically shielded cage with food and water available ad libitum. ECoG, EMG and LFPs (filtered 0.7-170 Hz, 1 KHz sampling) were recorded using the MAP data acquisition system (Plexon, Dallas, TX) and analyzed off-line using a software (NeuroExplorer, Nex Technology, Madison, AL).
The mice implanted electrodes were subjected to the cueevoked fear conditioning test. Baseline brain activity with and without 30 s buzzer sound as a CS was recorded in the recording chamber (LE100290, PanLab, Spain). Twenty-four hours later, fear conditioning was conducted using a chamber with metal grid (20 Â 20 Â 25 cm, Harvard Apparatus), simultaneously animals' behavior was recorded using an infrared camera. Three pairs of auditory CS and US (2 s, 0.3 mA electrical foot shock) delivered at the last 2 s of the CS period was controlled by a software (PACKWIN, Panlab, Spain). Again, 24 h after conditioning, brain activity of the conditioned mouse was recorded in the same chamber for a baseline recording. Freezing behavior was scored by the investigator blinded to genotypes of the mice. Power spectrum analysis of ECoG and LFPs were calculated (0-100 Hz, 0.5 Hz bin) by NeuroExplorer. Power densities corresponding to defined oscillations were summed for absolute LFP power (e.g. gamma: 50-70 Hz). Upon completion of the experiment using ECoG and LFP recordings, positions of electrodes and cannulas were verified histologically using hematoxylin and eosin staining (30 lm brain sections).
Statistics
Statistical analyses were performed using Prism 5 (GraphPad Software, La Jolla, CA, USA). Comparisons between two genotype groups were performed using Student's t-test, two-sided. When the variance of data set was significantly different, we used nonparametric statistical analysis, Mann-Whitney U test. P value smaller than 0.05 was considered significant. For comparison between genotypes in fear conditioning test, two-way repeated measures analysis of variance (ANOVA) with Bonferroni correction for multiple comparisons was applied. Data are represented as mean 6 standard error of mean (SEM). *P < 0.05, **P < 0.01, ***P < 0.001.
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